-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Constellium, Lowers Price Target to $18

Benzinga·10/24/2024 13:24:40
Listen to the news
BMO Capital analyst Katja Jancic maintains Constellium (NYSE:CSTM) with a Outperform and lowers the price target from $22 to $18.